
|Articles|April 1, 2004
Oral Rx for stress incontinence closer to approval
Sydney, Australia--Duloxetine, a selective serotonin and norepinephrinereuptake inhibitor, yields significant improvements in incontinent episodesand quality of life among women with stress urinary incontinence, and ispoised to become the first effective oral agent for the condition, an Australianurologist says.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mark Tyson, MD shares promising BOND-003 results in papillary NMIBC
2
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
3
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
4
Modern frameworks for treating high-risk non–muscle invasive bladder cancer
5

















